With 0.55 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.76 million shares. The 52-week range on VRNT shows that it touched its highest point at $38.17 and its lowest point at $21.27 during that stretch. It currently has a 1-year price target of $36.00. Beta for the stock currently stands at 1.25.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of VRNT was down-trending over the past week, with a drop of -4.28%, but this was down by -10.78% over a month. Three-month performance dropped to -11.35% while six-month performance fell -29.19%. The stock lost -28.99% in the past year, while it has lost -18.62% so far this year. A look at the trailing 12-month EPS for VRNT yields 0.95 with Next year EPS estimates of 3.11. For the next quarter, that number is 1.27. This implies an EPS growth rate of 6.16% for this year and 7.44% for next year. EPS is expected to grow by 7.61% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -22.59%.
Float and Shares Shorts:
At present, 62.28 million VRNT shares are outstanding with a float of 61.26 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for VRNT since 8 analysts follow the stock currently. There are 7 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $2.66154 being high and $2.62374 being low. For VRNT, this leads to a yearly average estimate of $2.65153. Based on analyst estimates, the high estimate for the next quarter is $0.7 and the low estimate is $0.57. The average estimate for the next quarter is thus $0.63.
Summary of Insider Activity:
Insiders traded VRNT stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.
